18 results on '"Mollier K"'
Search Results
2. Variable correction of Artemis deficiency by I-Sce1-meganuclease-assisted homologous recombination in murine hematopoietic stem cells
- Author
-
Rivière, J, Hauer, J, Poirot, L, Brochet, J, Souque, P, Mollier, K, Gouble, A, Charneau, P, Fischer, A, Pâques, F, de Villartay, J-P, and Cavazzana, M
- Published
- 2014
- Full Text
- View/download PDF
3. Restoration of B-cell development after lentiviral transduction of CD34+ haematopoietic cells from RAG-1 deficient patient
- Author
-
Lagresle-Peyrou, C., Charneau, P., Hue, C., Mollier, K., Andre-Schmutz, I., Bonhomme, D., Hacein-Bey-Abina, S., de Villartay, J. P., Fischer, A., and Cavazzana-Calvo, M.
- Published
- 2005
4. P17-20. Lentiviral vector-based vaccine against SIV infection and simian AIDS
- Author
-
Beignon, A, primary, Mollier, K, additional, Liard, C, additional, Munier, S, additional, Riviere, J, additional, Coutant, F, additional, Boulay, A, additional, Caleechurn, L, additional, Souque, P, additional, Bauche, C, additional, and Charneau, P, additional
- Published
- 2009
- Full Text
- View/download PDF
5. INK4a-ARF mutations in skin carcinomas from UV irradiated hairless mice
- Author
-
Soufir, N., primary, Queille, S., additional, Mollier, K., additional, Roux, E., additional, Sarasin, A., additional, de Gruijl, F.R., additional, Fourtanier, A.M., additional, Daya-Grosjean, L., additional, and Basset-Seguin, N., additional
- Published
- 2004
- Full Text
- View/download PDF
6. Rapid ex vivo protocol for efficient and stable gene transfer in the liver via hepatocyte transduction by flap lentiviral vectors
- Author
-
Giannini, C., primary, Morosan, S., additional, Tralhao, J.G., additional, Guidotti, J.E., additional, Battaglia, S., additional, Mollier, K., additional, Hannoun, L., additional, Kremsdorf, D., additional, and Charneau, P., additional
- Published
- 2003
- Full Text
- View/download PDF
7. Immunogenicity of a recombinant lentiviral vector carrying human telomerase tumor antigen in HLA-B*0702 transgenic mice.
- Author
-
Rusakiewicz S, Dosset M, Mollier K, Souque P, Charneau P, Wain-Hobson S, Langlade-Demoyen P, and Adotévi O
- Subjects
- Animals, Cell Line, Female, HLA-B Antigens genetics, HLA-B7 Antigen, Humans, Immunity, Cellular, Interferon-gamma immunology, Lentivirus immunology, Mice, Mice, Knockout, Mice, Transgenic, Vaccines, DNA immunology, Vaccines, Subunit immunology, Cancer Vaccines immunology, Genetic Vectors immunology, T-Lymphocytes, Cytotoxic immunology, Telomerase immunology
- Abstract
Over expression of telomerase represents a hallmark of cancer cells and the induction of T cell immunity against this universal tumor antigen have gained promising interest for anticancer immunotherapy. In this study we evaluated a recombinant lentiviral vector expressing the human telomerase reverse transcriptase (lv-hTERT) vaccination in the humanized HLA-B*0702 transgenic (HLA-B7 Tg) mice. A single lv-hTERT vector immunization induces potent and broad HLA-B7-restricted CTL responses against hTERT. Unlike conventional hTERT peptide or DNA immunization, the lv-hTERT vector triggers high and sustained IFN-gamma producing CD8(+) T cell responses in HLA-B7 Tg mice. The avidity and in vivo cytotoxicity of CD8(+) T cells were stronger in lv-hTERT vector-immunized mice than in hTERT peptide or DNA vaccinated groups. The study also showed that the use of prime-boost vaccination drastically improved the magnitude and strength of lentivector-primed CD8(+) T cells. Our data indicated that lentiviral delivery of hTERT is suitable for enhancing cellular immunity against hTERT and offers a promising alternative for telomerase-based cancer vaccine., ((c) 2010 Elsevier Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
8. Targeting human telomerase reverse transcriptase with recombinant lentivector is highly effective to stimulate antitumor CD8 T-cell immunity in vivo.
- Author
-
Adotévi O, Mollier K, Neuveut C, Dosset M, Ravel P, Fridman WH, Tartour E, Charneau P, Wain-Hobson S, and Langlade-Demoyen P
- Subjects
- Animals, CD8-Positive T-Lymphocytes cytology, Cancer Vaccines immunology, Cell Line, Tumor, Cell Proliferation, Cross-Priming immunology, Humans, Immunization, Lymphocyte Depletion, Mice, Neoplasms genetics, Neoplasms immunology, Neoplasms prevention & control, Peptides immunology, Recombination, Genetic, T-Lymphocytes, Cytotoxic cytology, T-Lymphocytes, Cytotoxic immunology, Telomerase genetics, CD8-Positive T-Lymphocytes immunology, Genetic Therapy, Genetic Vectors genetics, Immunity, Cellular immunology, Lentivirus genetics, Neoplasms therapy, Telomerase therapeutic use
- Abstract
The success of active immunotherapy is based on the vaccine's ability to overcome immune tolerance through recalibrating the immune system so that it is able to recognize tumor antigens as foreign rather than self. In this study, we used a lentiviral vector system to target human telomerase reverse transcriptase (lv-hTERT), a widely expressed tumor antigen. Immunization of HLA-A*0201 transgenic HHD mice with recombinant lv-hTERT vector induces potent and diversified cytotoxic T lymphocyte responses that recognize in vitro murine tumor cells, which overexpress telomerase. Compared with peptide-based vaccinations, the lv-hTERT vector triggers better and more sustained CD8(+) T-cell response against self/TERT epitope in vivo. The study found that the additional use of a heterologous boosted vaccination drastically improves self/TERT-specific CD8 responses in lv-hTERT primed mice. Both primary and long-lasting self/TERT-specific CD8(+) T-cell responses induced with Iv-hTERT vector required the presence of CD4 T cells in vivo. This lv-hTERT-based active immunotherapy efficiently inhibits the growth of telomerase expressing tumors (B16/HLA-A2.1 murine melanoma) in HHD mice. These data show that targeting hTERT with lentivector is highly effective in stimulating a broad range of CD8 T-cell immunity that can be exploited for cancer immunotherapy.
- Published
- 2010
- Full Text
- View/download PDF
9. Lentiviral vector-based prime/boost vaccination against AIDS: pilot study shows protection against Simian immunodeficiency virus SIVmac251 challenge in macaques.
- Author
-
Beignon AS, Mollier K, Liard C, Coutant F, Munier S, Rivière J, Souque P, and Charneau P
- Subjects
- Animals, Gene Products, gag administration & dosage, Gene Products, gag genetics, Gene Products, gag immunology, Humans, Macaca immunology, Major Histocompatibility Complex genetics, Major Histocompatibility Complex immunology, Male, Pilot Projects, Simian Acquired Immunodeficiency Syndrome immunology, Simian Acquired Immunodeficiency Syndrome prevention & control, Viremia, AIDS Vaccines immunology, Acquired Immunodeficiency Syndrome immunology, Acquired Immunodeficiency Syndrome prevention & control, Aspartic Acid Endopeptidases genetics, Aspartic Acid Endopeptidases immunology, Genetic Vectors genetics, Genetic Vectors immunology, Lentivirus genetics, Lentivirus immunology, Simian Immunodeficiency Virus immunology, Vaccination
- Abstract
AIDS vaccination has a pressing need for more potent vaccination vectors capable of eliciting strong, diversified, and long-lasting cellular immune responses against human immunodeficiency virus (HIV). Lentiviral vectors have demonstrated efficiency not only as gene delivery vehicles for gene therapy applications but also as vaccination tools. This is likely due to their ability to transduce nondividing cells, including dendritic cells, enabling sustained endogenous antigen presentation and thus the induction of high proportions of specific cytotoxic T cells and long-lasting memory T cells. We show in a first proof-of-concept pilot study that a prime/boost vaccination strategy using lentiviral vectors pseudotyped with a glycoprotein G from two non-cross-reactive vesicular stomatitis virus serotypes elicited robust and broad cellular immune responses against the vector-encoded antigen, simian immunodeficiency virus (SIV) GAG, in cynomolgus macaques. Vaccination conferred strong protection against a massive intrarectal challenge with SIVmac251, as evidenced both by the reduction of viremia at the peak of acute infection (a mean of over 2 log(10) fold reduction) and by the full preservation of the CD28(+) CD95(+) memory CD4(+) T cells during the acute phase, a strong correlate of protection against pathogenesis. Although vaccinees continued to display lower viremia than control macaques during the early chronic phase, these differences were not statistically significant by day 50 postchallenge. A not-optimized SIV GAG antigen was chosen to show the strong potential of the lentiviral vector system for vaccination. Given that a stronger protection can be anticipated from a modern HIV-1 antigen design, gene transfer vectors derived from HIV-1 appear as promising candidates for vaccination against HIV-1 infection.
- Published
- 2009
- Full Text
- View/download PDF
10. Lentiviral vectors encoding HIV-1 polyepitopes induce broad CTL responses in vivo.
- Author
-
Iglesias MC, Mollier K, Beignon AS, Souque P, Adotevi O, Lemonnier F, and Charneau P
- Subjects
- AIDS Vaccines genetics, AIDS Vaccines immunology, Animals, CD4-Positive T-Lymphocytes immunology, Cell Line, Cytotoxicity, Immunologic immunology, Epitopes, T-Lymphocyte genetics, Epitopes, T-Lymphocyte immunology, Genetic Vectors genetics, HIV-1 genetics, HIV-1 immunology, HLA-A2 Antigen genetics, HLA-B7 Antigen genetics, Humans, Immunization methods, Interferon-gamma metabolism, Lentivirus genetics, Mice, Mice, Transgenic, Viral Proteins genetics, HLA-A2 Antigen immunology, HLA-B7 Antigen immunology, T-Lymphocytes, Cytotoxic immunology, Viral Proteins immunology
- Abstract
Lentiviral vectors have been tested as vaccination vectors in anti-tumoral and anti-viral models. They efficiently transduce dendritic cells and stimulate strong T-cell responses against the encoded antigen. However, their capacity to stimulate a cytotoxic T-lymphocyte (CTL) response against several antigens has not been evaluated. Broad anti-human immunodeficiency virus 1 (HIV-1) T-cell immune responses are important for the control of HIV replication. We evaluated the potential of polyepitope-encoding lentiviral vectors to induce broad anti-HIV CTL responses. We constructed two lentiviral vectors coding for an HLA-A2- or HLA-B7-restricted polyepitope and evaluated their immunogenicity by direct injection of vector particles in HLA-A2 or HLA-B7 transgenic mice. In vitro cytotoxicity assays showed that a single immunization induces a strong, diversified, and long-lasting CTL response in both mouse models. CTL responses were directed against all 13 epitopes in the HLA-A2 system and 8 out of 12 in the HLA-B7 system. A second immunization augmented the number of responding mice in the HLA-A2 system but not in the HLA-B7 system. HLA-B7-immunized mice mounted strong interferon-gamma (IFN-gamma)-secreting T-cell responses against a majority of the epitopes and lysed peptide-loaded target cells in vivo. CTL responses in HLA-B7 mice were only partially dependent on CD4 T-cell help. This work underlines the potential of lentiviral vectors as candidates for therapeutic vaccination against acquired immunodeficiency syndrome.
- Published
- 2007
- Full Text
- View/download PDF
11. Nuclear import defect of human immunodeficiency virus type 1 DNA flap mutants is not dependent on the viral strain or target cell type.
- Author
-
Arhel N, Munier S, Souque P, Mollier K, and Charneau P
- Subjects
- HeLa Cells, Humans, Mutation, beta-Galactosidase analysis, beta-Galactosidase genetics, Active Transport, Cell Nucleus, DNA, Viral genetics, DNA, Viral metabolism, HIV-1 genetics, HIV-1 physiology
- Abstract
We have previously established, using human immunodeficiency virus type 1 (HIV-1) strain LAI, that the HIV-1 central DNA Flap acts as a cis determinant of viral genome nuclear import. Although the impact of the DNA Flap on nuclear import has already found numerous independent confirmations in the context of lentivirus vectors, it has been claimed that it may be nonessential for infectious virus strains LAI, YU-2 (J. D. Dvorin et al., J. Virol. 76:12087-12096, 2002), HXB2, and NL4-3 (A. Limon et al., J. Virol. 76:12078-12086, 2002). We conducted a detailed analysis of virus infectivity using the provirus clones provided by the authors and analogous target cells. In contrast to published data, our results show that all cPPT mutant viruses exhibit reduced infectivity corresponding to a nuclear import defect irrespective of the viral genetic background or target cell.
- Published
- 2006
- Full Text
- View/download PDF
12. Immunogenic HLA-B*0702-restricted epitopes derived from human telomerase reverse transcriptase that elicit antitumor cytotoxic T-cell responses.
- Author
-
Adotévi O, Mollier K, Neuveut C, Cardinaud S, Boulanger E, Mignen B, Fridman WH, Zanetti M, Charneau P, Tartour E, Lemonnier F, and Langlade-Demoyen P
- Subjects
- Animals, Cancer Vaccines immunology, Cell Line, DNA, HLA-B Antigens genetics, HLA-B7 Antigen, Humans, Immunotherapy methods, Mice, Mice, Transgenic, Neoplasms immunology, Neoplasms therapy, Peptide Fragments, Plasmids, Vaccination, Vaccines, Synthetic immunology, DNA-Binding Proteins metabolism, Epitopes, T-Lymphocyte immunology, HLA-B Antigens immunology, Telomerase metabolism
- Abstract
Purpose: The human telomerase reverse transcriptase (hTERT) is considered as a potential target for cancer immunotherapy because it is preferentially expressed in tumor cells. To increase the applicability of hTERT-based immunotherapy, we set out to identify CTL epitopes in hTERT restricted by HLA-B*0702 molecule, a common MHC class I allele., Experimental Design: HLA-B*0702-restricted peptides from hTERT were selected by using a method of epitope prediction and tested for their immunogenicity in human (in vitro) and HLA-B*0702 transgenic mice (in vivo)., Results: All the six hTERT peptides that were predicted to bind to HLA-B*0702 molecule were found to induce primary human CTL responses in vitro. The peptide-specific CD8+ CTL lines were tested against various hTERT+ tumor cells. Although differences were observed according to the tumor origin, only three CTL lines specific for p277, p342, and p351 peptides exhibited cytotoxicity against tumor cells in a HLA-B*0702-restricted manner. In addition, this cytotoxicity was inhibited by the addition of peptide-loaded cold target cells and indicated that these epitopes are naturally processed and presented on the tumor cells. Further, in vivo studies using humanized HLA-B*0702 transgenic mice showed that all the candidate peptides were able to induce CTL responses after peptide immunization. Furthermore, vaccination with a plasmid DNA encoding full-length hTERT elicited peptide-specific CTL responses, indicating that these epitopes are efficiently processed in vivo., Conclusions: Together with previously reported hTERT epitopes, the identification of new CTL epitopes presented by HLA-B*0702 increases the applicability of hTERT-based immunotherapy to treating cancer.
- Published
- 2006
- Full Text
- View/download PDF
13. A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus.
- Author
-
Iglesias MC, Frenkiel MP, Mollier K, Souque P, Despres P, and Charneau P
- Subjects
- Animals, Genetic Vectors, Humans, Immunization Schedule, Mice, Transduction, Genetic, Viral Envelope Proteins, West Nile virus immunology, Antibody Formation, Lentivirus genetics, Viral Vaccines immunology, West Nile Fever immunology, West Nile Fever prevention & control, West Nile virus pathogenicity
- Abstract
Background: Lentiviral vectors, due to their capacity to transduce non-dividing cells, have become precious and worldwide used gene transfer systems. Their ability to efficiently and stably transduce dendritic cells (DCs) has led to their successful use as vaccination vectors for eliciting strong, specific and protective cellular immune responses mostly in anti-tumoral but also in anti-viral applications. However, the ability of lentiviral vectors to elicit an antibody-based protective immunity has, to date, not been evaluated. In the present study, we evaluated the potential of a lentiviral vector-based vaccine to elicit humoral immunity against West Nile virus (WNV). WNV is a mosquito-borne flavivirus that emerged in North America and causes encephalitis in humans, birds and horses. Neutralizing anti-WNV antibodies have been shown to be crucial for protection against WNV encephalitis., Methods: The ability of lentiviral vector TRIP/sE(WNV), expressing the secreted soluble form of the envelope E-glycoprotein (sE(WNV)) from the highly virulent IS-98-ST1 strain of WNV, to induce a specific humoral response and protection against WNV infection was assessed in a mouse model of WNV encephalitis., Results: Remarkably, a single immunization with a minute dose of TRIP/sE(WNV) was efficient at eliciting a long-lasting, protective and sterilizing humoral immunity, only 1 week after priming., Conclusions: This study broadens the applicability of lentiviral vectors as efficient non-replicating vaccines against pathogens for which a neutralizing humoral response is one active arm of the protective immunity. The TRIP/sE(WNV) lentiviral vector appears to be a promising tool for veterinary vaccination against zoonotic WNV.
- Published
- 2006
- Full Text
- View/download PDF
14. Modulation of gene expression induced in human epidermis by environmental stress in vivo.
- Author
-
Marionnet C, Bernerd F, Dumas A, Verrecchia F, Mollier K, Compan D, Bernard B, Lahfa M, Leclaire J, Medaisko C, Mehul B, Seité S, Mauviel A, and Dubertret L
- Subjects
- Adult, Calgranulin A genetics, Calgranulin B genetics, Emollients, Environment, Epidermis drug effects, Epidermis radiation effects, Female, Gene Expression drug effects, Gene Expression radiation effects, Humans, Male, Petrolatum, Physical Stimulation, Reverse Transcriptase Polymerase Chain Reaction, Sodium Dodecyl Sulfate, Stimulation, Chemical, Stress, Physiological physiopathology, Surface-Active Agents, Ultraviolet Rays, Epidermis physiology, Gene Expression physiology, Oligonucleotide Array Sequence Analysis, Stress, Physiological genetics
- Abstract
Environmental insults on the skin induce biologic responses through the modulation of expression of genes implicated in different cell functions. The aim of this study was to investigate the modulation of gene expression profile in human epidermis in vivo following different stresses. We determined the modulations of gene expression using cDNA macroarray in the epidermis of 28 healthy volunteers, following mild and physiologic insults, including: (1), tape stripping; (2) application of 10% sodium dodecyl sulfate; (3) daily application of vaseline; and (4), exposure to one minimal erythema dose of solar-simulated radiation. The analysis was performed 19 h after treatment. The reverse transcription-polymerase chain reaction method was used to confirm our results. We showed that: (1) the intensity of gene modulation was variable among the volunteers following the same skin stress; (2) the nature and intensity of skin treatment modified the pattern of gene expression; and (3) some genes were modulated only by specific stress, some others are modulated irrespective of the stress. GADD45, Bax, SAS, and granulocyte chemotactic protein-2 were overexpressed exclusively following solar-simulated radiation, whereas tape stripping led to the modulation of genes implicated in different pathways (inflammation, cell proliferation, cell differentiation, detoxification, etc.). Concerning common gene modulation, MRP8 and MRP14 were highly upregulated in human skin epidermis after solar-simulated radiation, vaseline application or tape stripping, and to a lower extent after sodium dodecyl sulfate. Such upregulation of the MRP 8/14 genes was confirmed at the protein level in an ex-vivo skin culture model following tape stripping and solar-simulated radiation. Together, these results suggest that MRP8 and MRP14 may be general, yet highly sensitive, markers for a great variety of skin stresses and that they are implicated in several epidermal repair pathways.
- Published
- 2003
- Full Text
- View/download PDF
15. A highly efficient, stable, and rapid approach for ex vivo human liver gene therapy via a FLAP lentiviral vector.
- Author
-
Giannini C, Morosan S, Tralhao JG, Guidotti JE, Battaglia S, Mollier K, Hannoun L, Kremsdorf D, Gilgenkrantz H, and Charneau P
- Subjects
- Animals, Cell Differentiation, Cell Division, Cells, Cultured, Hepatocytes physiology, Hepatocytes transplantation, Humans, Mice, Mice, SCID, Phenotype, Rats, Transduction, Genetic, Transgenes genetics, Genetic Therapy methods, Genetic Vectors, Hepatocytes cytology, Lentivirus genetics
- Abstract
Allogenic hepatocyte transplantation or autologous transplantation of genetically modified hepatocytes has been used successfully to correct congenital or acquired liver diseases and can be considered as an alternative to orthotopic liver transplantation. However, hepatocytes are neither easily maintained in culture nor efficiently genetically modified and are very sensitive to dissociation before their reimplantation into the recipient. These difficulties have greatly limited the use of an ex vivo approach in clinical trials. In the present study, we have shown that primary human and rat hepatocytes can be efficiently transduced with a FLAP lentiviral vector without the need for plating and culture. Efficient transduction of nonadherent primary hepatocytes was achieved with a short period of contact with vector particles, without modifying hepatocyte viability, and using reduced amounts of vector. We also showed that the presence of the DNA FLAP in the vector construct was essential to reach high levels of transduction. Moreover, transplanted into uPA/SCID mouse liver, lentivirally transduced primary human hepatocytes extensively repopulated their liver and maintained a differentiated and functional phenotype as assessed by the stable detection of human albumin and antitrypsin in the serum of the animals for months. In conclusion, the use of FLAP lentiviral vectors allows, in a short period of time, a high transduction efficiency of human functional and reimplantable hepatocytes. This work therefore opens new perspectives for the development of human clinical trials based on liver-directed ex vivo gene therapy.
- Published
- 2003
- Full Text
- View/download PDF
16. Differential molecular profiling between skin carcinomas reveals four newly reported genes potentially implicated in squamous cell carcinoma development.
- Author
-
Marionnet C, Lalou C, Mollier K, Chazal M, Delestaing G, Compan D, Verola O, Vilmer C, Cuminet J, Dubertret L, and Basset-Séguin N
- Subjects
- Gene Expression Profiling, Humans, Nerve Tissue Proteins, RNA, Messenger metabolism, Carcinoma, Squamous Cell genetics, Cell Transformation, Neoplastic genetics, Gene Expression Regulation, Neoplastic, Skin Neoplasms genetics
- Abstract
Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are skin tumors with different invasive potential. In this work, we analysed mRNA differential expression between seven BCC and five SCC and their normal skin counterparts using 1176 cDNA macroarrays and verification by RT-PCR to identify genes modulated in each tumor type. We identified 37 genes commonly modulated in both tumors and four genes specifically modulated in SCC. Among these latter RhoC and EMMPRIN genes seem to be of particular interest and could participate in SCC aggressivity.
- Published
- 2003
- Full Text
- View/download PDF
17. G protein-dependent CCR5 signaling is not required for efficient infection of primary T lymphocytes and macrophages by R5 human immunodeficiency virus type 1 isolates.
- Author
-
Amara A, Vidy A, Boulla G, Mollier K, Garcia-Perez J, Alcamí J, Blanpain C, Parmentier M, Virelizier JL, Charneau P, and Arenzana-Seisdedos F
- Subjects
- Cell Line, Cells, Cultured, HIV Infections virology, HIV-1 physiology, Humans, Lentivirus genetics, Receptors, CCR5 genetics, Virus Replication, CD4-Positive T-Lymphocytes virology, GTP-Binding Proteins metabolism, HIV-1 pathogenicity, Macrophages virology, Receptors, CCR5 metabolism, Signal Transduction
- Abstract
The requirement of human immunodeficiency virus (HIV)-induced CCR5 activation for infection by R5 HIV type 1 (HIV-1) strains remains controversial. Ectopic CCR5 expression in CD4(+)-transformed cells or pharmacological inhibition of G(alpha)i proteins coupled to CCR5 left unsolved whether CCR5-dependent cell activation is necessary for the HIV life cycle. In this study, we investigated the role played by HIV-induced CCR5-dependent cell signaling during infection of primary CD4-expressing leukocytes. Using lentiviral vectors, we restored CCR5 expression in T lymphocytes and macrophages from individuals carrying the homozygous 32-bp deletion of the CCR5 gene (ccr5 Delta32/Delta32). Expression of wild-type (wt) CCR5 in ccr5 Delta32/Delta32 cells permitted infection by R5 HIV isolates. We assessed the capacity of a CCR5 derivative carrying a mutated DRY motif (CCR5-R126N) in the second intracellular loop to work as an HIV-1 coreceptor. The R126N mutation is known to disable G protein coupling and agonist-induced signal transduction through CCR5 and other G protein-coupled receptors. Despite its inability to promote either intracellular calcium mobilization or cell chemotaxis, the inactive CCR5-R126N mutant provided full coreceptor function to several R5 HIV-1 isolates in primary cells as efficiently as wt CCR5. We conclude that in a primary, CCR5-reconstituted CD4(+) cell environment, G protein signaling is dispensable for R5 HIV-1 isolates to actively infect primary CD4(+) T lymphocytes or macrophages.
- Published
- 2003
- Full Text
- View/download PDF
18. P16(INK4A) is implicated in both the immediate and adaptative response of human keratinocytes to UVB irradiation.
- Author
-
Chazal M, Marionnet C, Michel L, Mollier K, Dazard JE, Della Valle V, Larsen CJ, Gras MP, and Basset-Séguin N
- Subjects
- Blotting, Western, Bromodeoxyuridine, Cells, Cultured, Cyclin-Dependent Kinase Inhibitor p16 metabolism, Cyclin-Dependent Kinase Inhibitor p21, Cyclins genetics, Cyclins metabolism, DNA Primers chemistry, Dose-Response Relationship, Radiation, Flow Cytometry, Humans, Immunoblotting, Keratinocytes metabolism, Proto-Oncogene Proteins genetics, Proto-Oncogene Proteins metabolism, Proto-Oncogene Proteins c-mdm2, RNA, Messenger metabolism, Radiation Dosage, Reverse Transcriptase Polymerase Chain Reaction, Tumor Suppressor Protein p14ARF genetics, Tumor Suppressor Protein p14ARF metabolism, Tumor Suppressor Protein p53 genetics, Tumor Suppressor Protein p53 metabolism, Ultraviolet Rays, Up-Regulation, bcl-2-Associated X Protein, Cyclin-Dependent Kinase Inhibitor p16 genetics, Gene Expression Regulation radiation effects, Keratinocytes radiation effects, Nuclear Proteins, Proto-Oncogene Proteins c-bcl-2
- Abstract
The p16(INK4A-ARF) locus plays a crucial role in the control of cellular proliferation via both the Rb and P53 pathways. We previously demonstrated that this locus is altered in human skin carcinomas. In the present study we have studied the expression of the p16(INK4A-ARF) locus following UVB irradiation of normal human keratinocytes both at the mRNA (RT-PCR) and at the protein (Western blotting) levels. Our data confirmed that P16(INK4A) protein is induced by UVB at low (30 mJ cm(2)) and high (100 mJ cm(2)) doses and is observed after a single or repeated exposure implying that this response is involved in both the immediate and adaptative response to UVB. The apparent absence of induction p16(INK4A) mRNA suggested that P16(INK4A) protein is upregulated at the post-transcriptional level. Analysis by flow cytometry and BrdU staining indicated that the highest protein level of P16(INK4A) in the cells was associated with a G(2) cell cycle arrest. Comparative analysis of P16(INK4A) and P53 showed that they were differentially modulated in keratinocytes according to the UVB dose and regimen. Low, acute or repeated UVB exposures led to accumulation of both P16(INK4A) and p53, whereas at high UVB doses, P53 and P53-dependent genes were not induced or even downregulated and only a slight but reproducible stabilization of P16(INK4A) protein was observed. In our conditions, P14(ARF) did not seem to participate in the UV response in these cells as P14(ARF) protein did not vary. These results infer that P16(INK4A) plays a role in cell cycle regulation of keratinocytes submitted to UVB irradiation. They also reinforce our previous demonstration of the importance of inactivation of this gene in UV-induced skin carcinogenesis.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.